Current Medicinal Chemistry - Anti-Cancer Agents

Preface [ Hot Topic: Radiation Oncology as Mainstay of Modern Cancer Medicine (Guest Editors: Claus Belka & Verena Jendrossek)]
pp. i-ii(2)
Authors: Belka, Claus; Jendrossek, Verena

Disruption of Cell Death Signaling in Cancer: Impact on Disease Prognosis and Response to Therapy
pp. 319-326(8)
Authors: Guner, Dilek; Belka, Claus; Daniel, Peter T.

Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action
pp. 327-333(7)
Author: Lammering, G.

Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
pp. 334-342(9)
Authors: Marini, Patrizia; Belka, Claus

Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers
pp. 343-353(11)
Authors: Jendrossek, V.; Handrick, R.

New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2
pp. 354-359(6)
Authors: Petersen, Cordula; Baumann, Michael; Petersen, Sven

Radioprotection of Normal Tissue to Improve Radiotherapy: The Effect of the Bowman Birk Protease Inhibitor
pp. 360-363(4)
Authors: Dittmann, K. H.; Mayer, C.; Rodemann, H. P.

Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
pp. 364-374(11)
Authors: Weinmann, Martin; Welz, Stefan; Bamberg, Michael

Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
pp. 375-382(8)
Authors: Classen, Johannes; Budach, Wilfried